GALLIVAC IBD S706 NEO compressa effervescente per polli
GALLIVAC IBD S706 NEO compressa effervescente per polli
Authorised
- Infectious bursal disease virus, strain S706, Live
Product identification
Medicine name:
GALLIVAC IBD S706 NEO compressa effervescente per polli
Active substance:
- Infectious bursal disease virus, strain S706, Live
Target species:
-
Chicken
Route of administration:
-
In drinking water use
Product details
Active substance and strength:
-
Infectious bursal disease virus, strain S706, Live4.00/log10 cell culture infective dose 501.00Dose
Pharmaceutical form:
-
Effervescent tablet
Withdrawal period by route of administration:
-
In drinking water use
- Chicken
-
Meat and offal0day
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI01AD09
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Italy
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Immunological veterinary medicinal product application (Article 13d of Directive No 2001/82/EC)
Marketing authorisation holder:
- Boehringer Ingelheim Animal Health Italia S.p.A. In Breve Boehringer Ingelheim Ah It S.p.A.
Marketing authorisation date:
Manufacturing sites for batch release:
- Boehringer Ingelheim Animal Health France
Responsible authority:
- Ministry Of Health
Authorisation number:
- 100158
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Combined File of all Documents
This document does not exist in this language (English). You can find it in another language below.
Italian (PDF)
Published on: 28/12/2023
How useful was this page?:
